Health and Fitness Health and Fitness
Fri, November 4, 2011
[ Fri, Nov 04th 2011 ] - Market Wire
Quest Diagnostics gibt Markteinfhrung des Simplex .. - und Atemwegserkrankungs-Viren in Europa bekannt
[ Fri, Nov 04th 2011 ] - Market Wire
Fresh Start Private Management Inc. Closes Merger With Fresh Start Private, Inc.
[ Fri, Nov 04th 2011 ] - Market Wire
URBAN AG Names Billy V. Ray Jr. President and Member of Board of Directors
[ Fri, Nov 04th 2011 ] - Market Wire
CML HealthCare Inc. Celebrates Medical Radiation Technologists Week-November 6-12, 2011
[ Fri, Nov 04th 2011 ] - Market Wire
KCI und von Apax Partners geleitetes Konsortium geben Ende der Geschftsleitungsgesprche bekannt
[ Fri, Nov 04th 2011 ] - Market Wire
Santarus and Pharming Announce Presentation of Re .. Analyses of Data from Clinical Studies of RHUCIN
[ Fri, Nov 04th 2011 ] - Market Wire
Acorda Therapeutics Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
KCI e consrcio dirigidos pela Apax Partners anunciam concluso das conversaes sobre gesto executiva
[ Fri, Nov 04th 2011 ] - Market Wire
Ardea Biosciences Reports Recent Accomplishments, .. g Events and Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Highly Anticipated Drugs From BioSante and AEterna Zentaris May Not Be as Lucrative as Expected
[ Fri, Nov 04th 2011 ] - Market Wire
Cancer Treatments From Dendreon and Cell Therapeutics May Not Be as Lucrative as Hoped
[ Fri, Nov 04th 2011 ] - Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. Mixed Results for Diagnostic Substances Industry
[ Fri, Nov 04th 2011 ] - Market Wire
For The Earth Corporation Grows Globally
[ Fri, Nov 04th 2011 ] - Market Wire
Novadaq Reports Third Quarter 2011 Financial Results
[ Fri, Nov 04th 2011 ] - Market Wire
Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
[ Fri, Nov 04th 2011 ] - Market Wire
Quest Diagnostics anuncia el lanzamiento del test .. Direct para gripe y virus respiratorios en Europa
Thu, November 3, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
Galapagos wins 2011 Scrip Award for Biotech Company of the Year
[ Thu, Nov 03rd 2011 ] - Market Wire
Aoxing Pharmaceutical Company Announces Special Funding From Hebei Province in China
[ Thu, Nov 03rd 2011 ] - Market Wire
Humana Inc. to Present at the Credit Suisse 2011 Healthcare Conference
[ Thu, Nov 03rd 2011 ] - Market Wire
Sirona Biochem Announces New Grant of Stock Options
[ Thu, Nov 03rd 2011 ] - Market Wire
MSA Declares Fourth Quarter Dividend
[ Thu, Nov 03rd 2011 ] - Market Wire
Threshold Pharmaceuticals Reports Third Quarter 2011 Financial and Operational Results
[ Thu, Nov 03rd 2011 ] - Market Wire
AVI BioPharma Announces Third Quarter 2011 Financial Results and Recent Corporate Developments
[ Thu, Nov 03rd 2011 ] - Market Wire
BioElectronics' Study on Postoperative Pain Reduc .. ublished in the Aesthetic Plastic Surgery Journal
[ Thu, Nov 03rd 2011 ] - Market Wire
SpectraScience to Hold Business Update Conference Call on November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
MethylGene Reports Third Quarter 2011 Financial Results and Provides Clinical Update
[ Thu, Nov 03rd 2011 ] - Market Wire
Dynavax Prices Public Offering of Common Stock
[ Thu, Nov 03rd 2011 ] - Market Wire
Celsion Corporation to Hold Third Quarter 2011 Fi .. ts Conference Call on Thursday, November 10, 2011
[ Thu, Nov 03rd 2011 ] - Market Wire
SecureAlert, Inc. and Commonwealth of Puerto Rico .. Violence With Focus on Family Safety and Real-Tim
[ Thu, Nov 03rd 2011 ] - Market Wire
FONAR Reports Error in Reports Regarding Its Common Stock

FONAR Reports Error in Reports Regarding Its Common Stock


Published on 2011-11-03 04:50:00 - Market Wire
  Print publication without navigation


November 03, 2011 07:30 ET

FONAR Reports Error in Reports Regarding Its Common Stock

MELVILLE, NY--(Marketwire - Nov 3, 2011) - FONAR Corporation (NASDAQ: [ FONR ]), The Inventor of MR Scanning™, announced today that any reports of a call or redemption of any shares of any class of FONAR's securities, including its common stock cusip no. 344437405, are false. FONAR and its transfer agent have received inquiries and/or reports from third parties concerning a call of its stock. FONAR's stock is not callable and there is no call being considered by FONAR. FONAR does not know where this erroneous information originated.


Contributing Sources